November 28, 2014 10:50 PM ET

Pharmaceuticals

Company Overview of Symphony Icon, Inc.

Company Overview

Symphony Icon, Inc. operates as a pharmaceutical research and development company. It develops products for cognitive disorders, irritable bowel syndrome, and gastrointestinal disorders. The company was incorporated in 2007 and is based in the United States. As of July 30, 2010, Symphony Icon, Inc. operates as a subsidiary of Lexicon Pharmaceuticals, Inc.

,  

United States

Founded in 2007

Key Executives for Symphony Icon, Inc.

Symphony Icon, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Biotie Therapies, Inc. United States
GlaxoSmithKline Holdings (Americas) Inc. United States
Aires Pharmaceuticals, Inc. United States
STWB Inc. United States
Novo Nordisk of North America, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Symphony Icon, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.